ChemoMetec A/S (OCSE:CHEMM) Interest Expense : kr-2.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is ChemoMetec A/S Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ChemoMetec A/S's interest expense for the six months ended in Dec. 2023 was kr -1.8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was kr-2.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ChemoMetec A/S's Operating Income for the six months ended in Dec. 2023 was kr 84.6 Mil. ChemoMetec A/S's Interest Expense for the six months ended in Dec. 2023 was kr -1.8 Mil. ChemoMetec A/S's Interest Coverage for the quarter that ended in Dec. 2023 was 47.66. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ChemoMetec A/S Interest Expense Historical Data

The historical data trend for ChemoMetec A/S's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec A/S Interest Expense Chart

ChemoMetec A/S Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

-0.72

-1.19

-0.92

-1.48

-1.09

ChemoMetec A/S Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.78	-0.71	-0.85	-0.24	-1.78

ChemoMetec A/S Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-2.0 Mil.

ChemoMetec A/S (OCSE:CHEMM) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ChemoMetec A/S's Interest Expense for the six months ended in Dec. 2023 was kr-1.8 Mil. Its Operating Income for the six months ended in Dec. 2023 was kr84.6 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was kr2.6 Mil.

ChemoMetec A/S's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	84.645	/	-1.776
	=	47.66

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. ChemoMetec A/S has enough cash to cover all of its debt. Its financial situation is stable.

ChemoMetec A/S (OCSE:CHEMM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec A/S (OCSE:CHEMM) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

CHEMMc:UK 0DZ0:UK CHY:Germany

Address

Gydevang 43, Allerod, DNK, 3450

Website

https://www.chemometec.com

ChemoMetec A/S specializes in the design, development, and production of instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing, and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others.

ChemoMetec A/S (OCSE:CHEMM) Headlines

No Headlines